Knowing key facts about geographic atrophy, a leading cause of blindness, can help you manage the eye disease.

LAS VEGAS — In this video, Christine N. Kay, MD, discusses age-related macular degeneration updates presented at Clinical Trials at the Summit, including different treatment modalities for ...

Age-Dependent Integration of Cortical Progenitors Transplanted at CSF-Neurogenic Niche Interface Provisionally accepted Gretchen Greene 1* Nikorn Pothayee 1* Jahandar Jahanipour 1 Hyesoo Jie 1 ...

“We are pleased to announce the completion of enrollment in our pivotal clinical trial in geographic atrophy, a milestone that reflects strong global interest in our investigational therapy," says Dr.

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that Viatris Inc. ("Viatris"), has secured regulatory approval from China's National Medical ...

Biogen's early-stage spinal muscular atrophy drug salanersen showed safety, motor improvements and 70% reduction in neurodegeneration markers after one-year dosing.

Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in spinal muscular atrophy (SMA) Interim Phase 1 data show ...

Respiratory complications are common in spinal muscular atrophy (SMA) and significantly contribute to morbidity and mortality in these patients. Generalized respiratory and bulbar muscle weakness ...

Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 currently approved disease-modifying therapies that restore SMN protein ...